Clinical Trial: Linaprazan Glurate Capsules-Amoxicillin Dual Therapy for the Eradication of Helicobacter pylori Infection: A Prospective, Randomized, Open-Label Exploratory Real-World Study (China)

Posted On: 2026-11-11

China, Nov. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Linaprazan Glurate Capsules-Amoxicillin Dual Therapy for the Eradication of Helicobacter pylori Infection: A Prospective, Randomized, Open-Label Exploratory Real-World Study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600136415

Registration Time: 2026/11/10

Type: Interventional study

Primary Sponsor: Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=352201

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Linaprazan Glurate Capsules-Amoxicillin Dual Therapy for the Eradication of Helicobacter pylori Infection: A Prospective, Randomized, Open-Label Exploratory Real-World Study (China)